NPPA seeks clarification on Gilead's drug pricing plea

National Pharmaceutical Pricing Authority has sought clarifications
from the company. Gilead had sought exemption from price control for
its Tenofovir Alafenamide tablets (brand name Vemlidy) to capture a
major chunk of Rs 140-crore market for chronic Hepatitis B in India.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-seeks-clarification-on-gileads-drug-pricing-plea/articleshow/73788094.cms

Comments

Post a Comment

Popular posts from this blog

Sunday Worship Service

Event Date as Display String: Sunday, October 13, 2019, 11:00am - 12:00pm Location: The Memorial Church Sanctuary, 1 Harvard Yard, Cambridge URL: http://memorialchurch.harvard.edu Event Description: Anthems: J. S. Bach, Der Geist hilft unser Schwachheit auf, BWV 226. A multi-denominational Protestant worship service open to all regardless of faith, serving the Harvard University community and beyond. Services are broadcast live on WHRB 95.3 FM and at whrb.org . Sermons are available on SoundCloud: soundcloud.com … recordings of the service are available at memorialchurch.harvard.edu . UID: http://uid.trumba.com/event/134191598 Event Start Date as Date Type: Sunday, October 13, 2019 - 11:00 to 12:00 Thumbnail: https://www.trumba.com/i/DgDKJmBnPouoVWljHLMADwpU.jpg Detail Image: https://www.trumba.com/i/DgAzfdMTLO88RjnBtcqzZuqt.jpg Feature Image: Featured: No https://www.harvard.edu/preview/featured/events/sunday-worship-se...
Read more

India may soon line up for Putin’s once-scorned vaccine - now a favorite in pandemic fight

At least 20 countries have approved the inoculation for use, including European Union member-state Hungary, while key markets such as Brazil and India are close to authorizing it. Now Russia is setting its sights on the prized EU market as the bloc struggles with its vaccination program amid supply shortages. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-may-line-up-for-putins-once-scorned-vaccine-now-a-favorite-in-pandemic-fight/articleshow/80730895.cms
Read more